Realta Life Sciences, Inc.
Clinical trials sponsored by Realta Life Sciences, Inc., explained in plain language.
-
New drug could protect Babies' brains after birth complications
Disease control Recruiting nowThis study tests a drug called RLS-0071 in newborns who have brain damage from lack of oxygen during birth. The babies also receive standard cooling therapy. The goal is to see if the drug is safe and may help reduce brain injury. About 70 babies will take part, and they will be …
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for transplant patients: drug targets stubborn immune attack
Disease control Recruiting nowThis study tests a drug called RLS-0071 in 66 hospitalized patients who have severe graft-versus-host disease (GVHD) after a stem cell transplant and did not improve with steroids. The drug is given for 7 to 14 days to see if it is safe and helps control the immune reaction. The …
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC